When the good go bad: Mutant NPM1 in acute myeloid leukemia.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Blood reviews

• Publication date

  2017-04-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.blre.2017.11.001PMID 29157973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Imidazoquinoxaline derivative EAPB0503: A promising drug targeting mutant nucleophosmin 1 in acute myeloid leukemia

  2017cited by this paper
• Coexisting and cooperating mutations in NPM1-mutated acute myeloid leukemia.

  2017cited by this paper
• Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.

  2017cited by this paper
• RUNX1 mutations in acute myeloid leukemia are associated with distinct clinico-pathologic and genetic features

  2016cited by this paper
• IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives

  2016cited by this paper
• Activity of a selective inhibitor of nuclear export, selinexor (KPT-330), against AML-initiating cells engrafted into immunosuppressed NSG mice

  2016cited by this paper
• A redox mechanism underlying nucleolar stress sensing by nucleophosmin

  2016cited by this paper
• Molecules that target nucleophosmin for cancer treatment: an update

  2016cited by this paper
• Nucleophosmin mutation in de‐novo acute myeloid leukemia

  2016cited by this paper
• ‘Acute myeloid leukemia: a comprehensive review and 2016 update'

  2016cited by this paper
• Negative regulation of DNMT3A de novo DNA methylation by frequently overexpressed UHRF family proteins as a mechanism for widespread DNA hypomethylation in cancer

  2016cited by this paper
• Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia.

  2016cited by this paper
• Efficient DNA binding of NF-κB requires the chaperone-like function of NPM1

  2016cited by this paper
• A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1–HAUS1

  2016cited by this paper
• The Mechanism By Which Mutant Nucleophosmin (NPM1) Creates Leukemic Self-Renewal Is Readily Reversed

  2016cited by this paper
• Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia

  2016cited by this paper
• Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells.

  2015cited by this paper
• Transcriptional Heterogeneity and Lineage Commitment in Myeloid Progenitors.

  2015cited by this paper
• Acute Promyelocytic Leukemia: A Review and Discussion of Variant Translocations.

  2015cited by this paper
• Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia.

  2015cited by this paper
• HSP90 inhibition leads to degradation of the TYK2 kinase and apoptotic cell death in T-cell acute lymphoblastic leukemia

  2015cited by this paper
• Retinoic acid and arsenic trioxide trigger degradation of mutated NPM1, resulting in apoptosis of AML cells.

  2015cited by this paper
• Development of a flow cytometric method to detect the presence of mutated nucleophosmin 1 in acute myeloid leukemia.

  2015cited by this paper
• Interactions of the natural product (+)-avrainvillamide with nucleophosmin and exportin-1 Mediate the cellular localization of nucleophosmin and its AML-associated mutants.

  2015cited by this paper
• Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia.

  2015cited by this paper
• Anti-tumor activity of selective inhibitors of XPO1/CRM1-mediated nuclear export in diffuse malignant peritoneal mesothelioma: the role of survivin

  2015cited by this paper
• Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations

  2014cited by this paper
• The Epigenetic Landscape of Acute Myeloid Leukemia

  2014cited by this paper
• Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro

  2014cited by this paper
• Targeting nucleophosmin 1 represents a rational strategy for radiation sensitization.

  2014cited by this paper
• Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology

  2014cited by this paper
• DNMT3A is a Powerful Follow-up Marker in NPM1 mutated AML

  2014cited by this paper
• EAPB0503, a novel imidazoquinoxaline derivative, inhibits growth and induces apoptosis in chronic myeloid leukemia cells

  2014cited by this paper
• Structural polymorphism in the N-terminal oligomerization domain of NPM1

  2014cited by this paper
• Phosphorylation of multifunctional nucleolar protein nucleophosmin (NPM1) by aurora kinase B is critical for mitotic progression

  2014cited by this paper
• Nucleophosmin modulates stability, activity, and nucleolar accumulation of base excision repair proteins

  2014cited by this paper
• Prognostic significance of NPM1 mutations in acute myeloid leukemia: A meta-analysis.

  2014cited by this paper
• The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML

  2014cited by this paper
• Down-regulated expression of NPM1 in IMS-M2 cell line by (-)-epigallocatechin-3-gallate.

  2014cited by this paper
• NPM1 Silencing Reduces Tumour Growth and MAPK Signalling in Prostate Cancer Cells

  2014cited by this paper
• Flt3 signaling regulates the proliferation, survival, and maintenance of multipotent hematopoietic progenitors that generate B cell precursors.

  2014cited by this paper
• Selective inhibitors of nuclear export (SINE)– a novel class of anti-cancer agents

  2014cited by this paper
• A novel insertion ins(18;5)(q21.1;q31.2q35.1) in acute myeloid leukemia associated with microdeletions at 5q31.2, 5q35.1q35.2 and 18q12.3q21.1 detected by oligobased array comparative genomic hybridization

  2014cited by this paper
• A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.

  2014cited by this paper
• Prognostic role of nucleophosmin in colorectal carcinomas.

  2014cited by this paper
• Interaction with RXR is necessary for NPM-RAR-induced myeloid differentiation blockade.

  2013cited by this paper
• Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

  2013cited by this paper
• Nucleophosmin mutations in acute myeloid leukemia: A tale of protein unfolding and mislocalization

  2013cited by this paper
• Mutation of NPM1 and FLT3 Genes in Acute Myeloid Leukemia and Their Association with Clinical and Immunophenotypic Features

  2013cited by this paper
• Molecular genetic tests for FLT3, NPM1, and CEBPA in acute myeloid leukemia.

  2013cited by this paper
• Translocation t(5;18)(q35;q21) as a Rare Nonrandom Abnormality in Acute Myeloid Leukemia

  2013cited by this paper
• Caspase functions in cell death and disease.

  2013cited by this paper
• In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline

  2013cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• Structure of Nucleophosmin DNA-binding Domain and Analysis of Its Complex with a G-quadruplex Sequence from the c-MYC Promoter*

  2012cited by this paper
• Multivalent Pseudopeptides Targeting Cell Surface Nucleoproteins Inhibit Cancer Cell Invasion through Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) Release*

  2012cited by this paper
• The CRM1 nuclear export protein in normal development and disease.

  2012cited by this paper
• The NPM1 wild-type OCI-AML2 and the NPM1-mutated OCI-AML3 cell lines carry DNMT3A mutations

  2012cited by this paper
• NPM-MLF1 synergizes with Npm haploinsufficiency to enhance myeloid progenitor activity

  2012cited by this paper
• Plant natural compounds: targeting pathways of autophagy as anti‐cancer therapeutic agents

  2012cited by this paper
• MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status

  2012cited by this paper
• S-nitrosylation of B23/nucleophosmin by GAPDH protects cells from the SIAH1–GAPDH death cascade

  2012cited by this paper
• NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases

  2012cited by this paper
• miR-10a is aberrantly overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death

  2012cited by this paper
• Landscape of TET2 mutations in acute myeloid leukemia

  2012cited by this paper
• Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

  2012cited by this paper
• The Multifunctional Nucleolar Protein Nucleophosmin/NPM/B23 and the Nucleoplasmin Family of Proteins

  2011cited by this paper
• Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas

  2011cited by this paper
• TET genes: new players in DNA demethylation and important determinants for stemness.

  2011cited by this paper
• Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

  2011cited by this paper
• Nucleophosmin and its complex network: a possible therapeutic target in hematological diseases

  2011cited by this paper
• Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?

  2011cited by this paper
• Anaplastic lymphoma kinase in human cancer.

  2011cited by this paper
• Detection of nucleophosmin 1 mutations by quantitative real-time polymerase chain reaction versus capillary electrophoresis: a comparative study.

  2011cited by this paper
• Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.

  2011cited by this paper
• IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.

  2010cited by this paper
• Pharmacology of EAPB0203, a novel imidazo[1,2-a]quinoxaline derivative with anti-tumoral activity on melanoma.

  2010cited by this paper
• Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.

  2010cited by this paper
• Molecular and alternative methods for diagnosis of acute myeloid leukemia with mutated NPM1: flexibility may help

  2010cited by this paper
• MYC as a regulator of ribosome biogenesis and protein synthesis

  2010cited by this paper
• Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism.

  2010cited by this paper
• DNMT3A mutations in acute myeloid leukemia.

  2010cited by this paper
• Translationally controlled tumor protein interacts with nucleophosmin during mitosis in ES cells

  2010cited by this paper
• Strikingly different molecular relapse kinetics in NPM1c, PML-RARA, RUNX1-RUNX1T1, and CBFB-MYH11 acute myeloid leukemias.

  2010cited by this paper
• Recruitment of phosphorylated NPM1 to sites of DNA damage through RNF8-dependent ubiquitin conjugates.

  2010cited by this paper
• Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.

  2010cited by this paper
• Polo-Like Kinase 2-Dependent Phosphorylation of NPM/B23 on Serine 4 Triggers Centriole Duplication

  2010cited by this paper
• Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1).

  2010cited by this paper
• Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels*

  2010cited by this paper
• Mutant nucleophosmin deregulates cell death and myeloid differentiation through excessive caspase-6 and -8 inhibition.

  2010cited by this paper
• Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications

  2009cited by this paper
• Anaplastic lymphoma kinase: signalling in development and disease

  2009cited by this paper
• Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutation

  2009cited by this paper
• New imidazo[1,2-a]quinoxaline derivatives: synthesis and in vitro activity against human melanoma.

  2009cited by this paper
• Role of nucleophosmin in acute myeloid leukemia

  2009cited by this paper
• Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity

  2009cited by this paper
• Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36

  2009cited by this paper
• Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype

  2009cited by this paper
• Acetylated NPM1 Localizes in the Nucleoplasm and Regulates Transcriptional Activation of Genes Implicated in Oral Cancer Manifestation

  2009cited by this paper
• HAUS, the 8-subunit human Augmin complex, regulates centrosome and spindle integrity.

  2009cited by this paper

• CD44 knockdown alters miRNA expression and their target genes in colon cancer

  2025cites this paper
• The nucleolar granular component mediates genome-nucleolus interactions and establishes their repressive chromatin states.

  2025cites this paper
• NPM1-Mutated AML: Deciphering the Molecular and Clinical Puzzle in the Era of Novel Treatment Strategies

  2025cites this paper
• From genotype to phenotype: decoding mutations in blasts by holo-tomographic flow cytometry

  2025cites this paper
• Retinoic acid disrupts an NPM1c/ROS/SENP3/ARF oncogenic axis in acute myeloid leukemia

  2025cites this paper
• Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India.

  2025cites this paper
• The Prognostic Value of Integrating Copy Number Alteration Profiles in NPM1-Mutated Acute Myeloid Leukemia: An Exploratory Study

  2025cites this paper
• IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia

  2025cites this paper
• NPM1-fusion proteins promote myeloid leukemogenesis through XPO1-dependent HOX activation

  2024cites this paper
• Evaluation of a New Closed-System Automated RT-qPCR Assay for the Rapid Detection and Monitoring of Common Nucleophosmin Mutations in Patients with Acute Myeloid Leukemia

  2024cites this paper
• NPM1 mediates genome-nucleolus interactions and the establishment of their repressive chromatin states

  2024cites this paper
• Myeloid neoplasm with <10% blasts and t(3;5)(q25.1;q34)/NPM::MLF1: A classification dilemma

  2024cites this paper
• The significance of HAUS1 and its relationship with immune microenvironment in hepatocellular carcinoma

  2024cites this paper
• Effect of lncRNA XIST on acute myeloid leukemia cells via miR-142-5p-PFKP axis

  2024cites this paper
• Clinical Significance of NPM1 A and Non A Mutations and Its Relation to The ARF/P53 Pathway in Egyptian Acute Myeloid Leukemia Patients

  2024cites this paper
• Expression of the long noncoding RNA CASC2 in acute myeloid leukemia and its prognostic significance.

  2024cites this paper
• Molecular Analysis of Genes CEBPA, NPM1, IDH1, and RUNX1 Polymorphisms as Biomarker Potential in Leukemia Patients

  2024cites this paper
• Prognostication refinement in NPM1‐mutated acute myeloid leukemia stratified by FLT3‐ITD status with different induction doses of cytarabine

  2023cites this paper
• Prognostic impact of FLT3‐ITD mutation on NPM1+ acute myeloid leukaemia patients and related molecular mechanisms

  2023cites this paper
• The induction of p53 correlates with defects in the production, but not the levels, of the small ribosomal subunit and stalled large ribosomal subunit biogenesis

  2023cites this paper
• Clinical features and prognostic significance of DNMT3A, FLT3, and NPM1 mutations in de novo acute myeloid leukemia patients

  2023cites this paper
• XPO1 is a new target of homoharringtonine (HHT): Making NPMc+ AML cells much more sensitive to HHT treatment.

  2023cites this paper
• Outcome of Post Induction Therapy for Acute Myeloid Leukemia in Nanakaly Hospital-Erbil

  2023cites this paper
• Nucleophosmin 1 associating with engulfment and cell motility protein 1 regulates hepatocellular carcinoma cell chemotaxis and metastasis

  2023influential citation
• Development of an in vitro genotoxicity assay to detect retroviral vector-induced lymphoid insertional mutants

  2023cites this paper
• Retinoic acid signaling in development and differentiation commitment and its regulatory topology.

  2023cites this paper
• Gold is gold even in mud: NPM1 mutations in T-AML.

  2023cites this paper
• Prospective Identification of Prognostic Hot-Spot Mutant Gene Signatures for Leukemia: A Computational Study Based on Integrative Analysis of TCGA and cBioPortal Data

  2023cites this paper
• Circular RNAs Activity in the Leukemic Bone Marrow Microenvironment

  2022cites this paper
• A newly identified interaction between nucleolar NPM1/B23 and the HTLV-I basic leucine zipper factor in HTLV-1 infected cells

  2022cites this paper
• The evolution of targeted therapy in pediatric AML: gemtuzumab ozogamicin, FLT3/IDH/BCL2 inhibitors, and other therapies.

  2022cites this paper
• Caspase-2 is a mediator of apoptotic signaling in response to gemtuzumab ozogamicin in acute myeloid leukemia

  2022cites this paper
• Nucleophosmin 1: from its pathogenic role to a tantalizing therapeutic target in acute myeloid leukemia

  2022cites this paper
• Type C mutation of nucleophosmin 1 acute myeloid leukemia: Consequences of intrinsic disorder.

  2022cites this paper
• Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis

  2022cites this paper
• Trasplante alogénico en leucemia mieloide aguda y la importancia genética en desarrollo de nuevos tratamientos

  2022cites this paper
• Functional characterization of NPM1–TYK2 fusion oncogene

  2022cites this paper
• Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia.

  2022cites this paper
• Mining of transcriptome identifies CD109 and LRP12 as possible biomarkers and deregulation mechanism of T cell receptor pathway in Acute Myeloid Leukemia

  2022cites this paper
• 2′O-Ribose Methylation of Ribosomal RNAs: Natural Diversity in Living Organisms, Biological Processes, and Diseases

  2021influential citation
• Preclinical Evaluation of Gilteritinib on NPM1-ALK–Driven Anaplastic Large Cell Lymphoma Cells

  2021cites this paper
• Ex vivo glucocorticoid‐induced secreted proteome approach for discovery of glucocorticoid‐responsive proteins in human serum

  2021cites this paper
• Short loop functional commonality identified in leukaemia proteome highlights crucial protein sub-networks

  2021cites this paper
• High expression of COMMD7 is an adverse prognostic factor in acute myeloid leukemia

  2021cites this paper
• Current views on the genetic landscape and management of variant acute promyelocytic leukemia

  2021cites this paper
• The potential role of nucleophosmin (NPM1) in the development of cancer

  2021cites this paper
• A Pin1/PML/P53 axis activated by retinoic acid in NPM-1c acute myeloid leukemia

  2021cites this paper
• Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia.

  2021cites this paper
• Azacytidine plus olaparib for relapsed acute myeloid leukaemia, ineligible for intensive chemotherapy, diagnosed with a synchronous malignancy

  2021cites this paper
• The Interpretation of Sequence Variants in Myeloid Neoplasms.

  2021cites this paper
• Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status

  2021cites this paper
• AML-Related NPM Mutations Drive p53 Delocalization into the Cytoplasm with Possible Impact on p53-Dependent Stress Response

  2021cites this paper
• The correlation of next-generation sequencing-based genotypic profiles with clinicopathologic characteristics in NPM1-mutated acute myeloid leukemia

  2021cites this paper
• Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphoma

  2021cites this paper
• Acute Leukemias

  2021cites this paper
• Significance of NPM1 Gene Mutations in AML

  2021cites this paper
• Molecular study of Nucleophosmin 1(NPM1) gene in acute myeloid leukemia in Kurdish population

  2021cites this paper
• ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape

  2021cites this paper
• Molecular study of Nucleophosmin 1(NPM1) gene in acute myeloid leukemia in Kurdish population

  2021cites this paper
• NPM1 mutant maintains ULK1 protein stability via TRAF6‐dependent ubiquitination to promote autophagic cell survival in leukemia

  2020cites this paper
• Acute Leukemia of Myeloid, Lymphoid, and Ambiguous Lineage and Related Malignancies

  2020cites this paper
• Clinical Presentation, Diagnosis, and Classification of Acute Myeloid Leukemia

  2020cites this paper
• Clinicopathologic Characterization of Hypocellular Acute Myeloid Leukemia (AML) Showed Fewer Genetic Abnormalities Involving Cell Proliferation and NPM1 When Compared With Nonhypocellular AML.

  2020cites this paper
• The role of autophagy in targeted therapy for acute myeloid leukemia

  2020cites this paper
• Proteostasis unbalance of nucleophosmin 1 in Acute Myeloid Leukemia: An aggregomic perspective.

  2020cites this paper
• T95 Nucleophosmin Phosphorylation as a Novel Mediator and Marker of Regulated Cell Death in Acute Kidney Injury.

  2020cites this paper
• Nucleophosmin in Its Interaction with Ligands

  2020influential citation
• Long non-coding RNA LINC01268 promotes cell growth and inhibits cell apoptosis by modulating miR-217/SOS1 axis in acute myeloid leukemia

  2020cites this paper
• Prognostic value of CD25/CD123 pattern of expression in acute myeloid leukemia patients with normal cytogenetic

  2020cites this paper
• Genotypic and phenotypic characteristics of acute promyelocytic leukemia translocation variants.

  2020cites this paper
• CD40 is Positively Correlated with the Expression of Nucleophosmin in Cisplatin-Resistant Bladder Cancer

  2020cites this paper
• Increased circulating vascular endothelial growth factor in acute myeloid leukemia patients: a systematic review and meta-analysis

  2020cites this paper
• NPM1 upregulates the transcription of PD-L1 and suppresses T cell activity in triple-negative breast cancer

  2020cites this paper
• Landscape of Tumor Suppressor Mutations in Acute Myeloid Leukemia

  2020cites this paper
• Nucleophosmin1 (NPM1) abnormality in hematologic malignancies, and therapeutic targeting of mutant NPM1 in acute myeloid leukemia

  2020cites this paper
• miRNA–mRNA Profiling Reveals Prognostic Impact of SMC1A Expression in Acute Myeloid Leukemia

  2020cites this paper
• Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia

  2020cites this paper
• NAT10 upregulation indicates a poor prognosis in acute myeloid leukemia.

  2020cites this paper
• Up‐regulation of DDIT4 predicts poor prognosis in acute myeloid leukaemia

  2019cites this paper
• The Value of FLT3, NPM1 and DNMT3A Gene Mutation Analysis in Acute Myeloid Leukemia Diagnosis

  2019cites this paper
• H3K27me3-rich genomic regions can function as silencers to repress gene expression via chromatin interactions

  2019cites this paper
• The acute myeloid leukemia‐associated Nucleophosmin 1 gene mutations dictate amyloidogenicity of the C‐terminal domain

  2019cites this paper
• Molecular diagnostics and risk assessment in myeloid malignancies

  2019cites this paper
• Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives

  2018cites this paper
• A novel type of NPM1 mutation characterized by multiple internal tandem repeats in a case of cytogenetically normal acute myeloid leukemia

  2018cites this paper
• FOXM1 contributes to treatment failure in acute myeloid leukemia

  2018cites this paper
• CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas

  2017cites this paper